Joshua Silverman - Nov 24, 2021 Form 4 Insider Report for MyMD Pharmaceuticals, Inc. (MYMD)

Role
Director
Signature
/s/ Joshua Silverman
Stock symbol
MYMD
Transactions as of
Nov 24, 2021
Transactions value $
$103,358
Form type
4
Date filed
11/29/2021, 11:46 AM
Previous filing
Oct 15, 2021
Next filing
Jan 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYMD Common Stock Purchase $42.4K +6.73K +9.13% $6.30 80.5K Nov 24, 2021 Direct F1
transaction MYMD Common Stock Purchase $23.2K +3.27K +4.06% $7.09 83.8K Nov 24, 2021 Direct F2
transaction MYMD Common Stock Purchase $37.8K +5K +5.97% $7.55 88.8K Nov 26, 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.96, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.17, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.07 to $7.70, inclusive.